Philipp Hoegen - Concepedia

Author

Philipp Hoegen

German Cancer Research Center

Also Known As

Hoegen, Philipp, P Hoegen, P. Hoegen, Peter Hoegen, Philipp Hoegen

Publications

620

Citations

H-Index

Concepts

All Affiliations

German Cancer Research Center Heidelberg University University Hospital Heidelberg National Center for Tumor Diseases Heidelberger Institut für Radioonkologie

About

Philipp Hoegen is an author at German Cancer Research Center specializing in oncology, radiation oncology, and radiation therapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	3	3	52
2	Medicine	3	3	52
3	Nursing	1	1	12
4	Hepatology	1	1	23
5	Obstetrics	1	1	12

Philipp Hoegen

Publications

567

Citations

H-Index

Page 1

	Year	Citations
Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients Laila König, Matthias Häfner, Sonja Katayama, Radiation Oncology	2020	56
Palliative Radiotherapy for Leptomeningeal Carcinomatosis–Analysis of Outcome, Prognostic Factors, and Symptom Response Rami A. El Shafie, Karina Böhm, Dorothea Weber, Frontiers in Oncology	2019	54
Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Tumors: Initial Clinical Experience and Patient-Reported Outcomes Fabian Weykamp, Philipp Hoegen, Sebastian Klüter, Frontiers in Oncology	2021	40
Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations Sebastian Regnery, Carolin Buchele, Fabian Weykamp, Frontiers in Oncology	2022	37
Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer Fabian Weykamp, Laila König, Katharina Seidensaal, Frontiers in Oncology	2020	36
Pre-Operative Versus Post-Operative Radiosurgery of Brain Metastases—Volumetric and Dosimetric Impact of Treatment Sequence and Margin Concept Rami A. El Shafie, Eric Tonndorf‐Martini, Daniela Schmitt, Cancers	2019	34
Cone-Beam-CT Guided Adaptive Radiotherapy for Locally Advanced Non-small Cell Lung Cancer Enables Quality Assurance and Superior Sparing of Healthy Lung Philipp Hoegen, Clemens Lang, Sati Akbaba, Frontiers in Oncology	2020	31
Secondary Malignancy Risk Following Proton vs. X-ray Treatment of Mediastinal Malignant Lymphoma: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk Laila König, P. Haering, Clemens Lang, Frontiers in Oncology	2020	26
MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial Philipp Hoegen, K. S. Zhang, Eric Tonndorf‐Martini, Radiation Oncology	2022	25
Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3) Sebastian Regnery, Jonas Ristau, Fabian Weykamp, Radiation Oncology	2022	24

Page 1